Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Date:8/29/2007

/p>

will highlight outcomes within the high-risk diabetic subset. The

Company plans to issue a press release at this time.

Tuesday, September 4

-- TAXUS II long-term data. At 9:45 a.m., five-year clinical follow-up

results from the TAXUS II clinical trial will be presented by Antonio

Colombo, M.D., the study's principal investigator, in the Helsinki Room

(Zone 2). TAXUS II is a randomized, double-blind, controlled study of

the safety and efficacy of the TAXUS Paclitaxel-Eluting Coronary Stent,

in which two sequential cohorts of patients with standard risk, de novo

coronary artery lesions were treated with different dose formulations

versus a bare-metal stent control group. The Company plans to issue a

press release at this time.

-- Cardiac Rhythm Management Workshop Session. At 12:45 p.m., the Company

will host a workshop entitled "Cardiac Resynchronisation Therapy: all

you need to know to maximize patient follow-up," in the Cairo Room

(Zone 2). The session will address the current status of CRT, the

value of HF diagnostics after device implant, and hemodynamic

optimization during CRT.

-- Symposium on Drug-Eluting Stents. At 2:00 p.m., the Company will host

a symposium entitled "What's the evidence for using drug-eluting stents

in your patients," chaired by H.D. Glogar, M.D., and Donald S. Baim,

M.D., in the Brussels Room (Zone 4). The symposium will focus on

current treatment options for coronary artery disease, latest

challenges in ULMCA (Unprotected Left Main Coronary Artery) with PCI,

evidence-based medicine for diabetics, real world data, and future

outlook for DES.

Wednesday, September 5

-- TAXUS in Women study. Results from the TAXUS WOMAN study, a gender

specific sub-group analysis of the TAXUS II - VI trials
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Inspire Announces Presentations at Two European Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Amgen (NASDAQ: AMGN ... partner and managing director of Warburg Pincus LLC, to the ... to welcome Fred Hassan and the deep, global ... Board," said Robert A. Bradway , chairman and chief ... to innovation will serve Amgen well." Mr. Hassan ...
(Date:7/30/2015)...  Cleveland Clinic President Wael Barsoum , M.D. ... that industry is compelled to adopt declining reimbursements throughout ... develop the transformational innovations -- required to thrive in ... by Doug Kohrs , past President and CEO ... that industry must add "episode of care," also known ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Aug. 4 Biomoda, Inc. (OTC,Bulletin Board: BMOD) ... submitted to the FDA a pre-IDE (Investigational Device,Exemption) ... assay,for detection of early lung cancer in veterans. ... million over two years towards the,study that will ...
... Rx, a specialty,pharmaceutical company leveraging its proprietary ... products, today announced the,completion of pilot product ... oxalate, a selective serotonin reuptake inhibitor.,Escitalopram oxalate ... and is marketed under the brand name ...
Cached Medicine Technology:FDA Reviewing Biomoda Submission for Cancer Screening Study 2MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 2MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 3
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... According to the article published ... of the Pasadena courthouse was contained and extinguished by the city’s fire department before it ... the building at the time of the fire, and it was a fire alarm system ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries and ... cakes with custom designs, making life just a little bit sweeter for newlyweds. ... for each customer who orders one. , The bakery provides a full line of ...
(Date:7/31/2015)... ... , ... Cosmetic Town has proven itself as the leader ... procedures including, but not limited to, abdominoplasty, blepharoplasty, rhinoplasty and septoplasty. The ... , Staying up to date with the latest cosmetic trends has never ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 New York ... family members, medical professionals, and researchers, covering a variety of topics related to ... collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering Cancer ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the ... in pursuit of a visionary image that goes beyond the boundaries of fertility medicine. ... IVF has reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and ...
Breaking Medicine News(10 mins):Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3
... LINTHICUM, MD. The AUA is pleased to announce their ... Cancer. Each year, more than 60,000 people are diagnosed ... number of risk factors, including cigarette smoking and exposure ... in 1999 and the report issued today is an ...
... universal hepatitis B immunisation means that most UK citizens ... in this weeks BMJ. , The UK is one ... routinely immunise children against hepatitis B, despite a call ... of vaccine prevention programmes by 1997, writes Andrew Pollard, ...
... binge drinking in the UK rise, doctors in this weeks ... attended hospital with lower abdominal pain. , Although rare, this ... alcohol intake. , Alcohol misuse is costing the NHS up ... by alcohol dependence or poisoning and 22,000 premature deaths each ...
... settlement as ,the ... right thing to do, HOUSTON, Nov. ... agreement with pharmaceutical giant,Merck & Co. Inc. (NYSE: MRK ) that ... over Vioxx, the company,s,controversial pain medication. (Photo: http://www.newscom.com/cgi-bin/prnh/20060623/DAF008 ) ...
... Provides Preliminary Information on Recapitalizations, Asset Sales and ... Anticipated Pre-Tax Charges ... on Accounting Restatement, MCLEAN, Va., Nov. 9 Sunrise Senior Living,Inc. ... the quarter ended September 30, 2007. The Company also,provided preliminary information on ...
... Client Development Officer, SOMERSET, N.J., Nov. 9 ... it has created a new Client Development,and Integration team. ... was recently,promoted to Chief Client Development Officer. The ... across the company,s segments to identify new opportunities to,serve ...
Cached Medicine News:Health News:AUA releases new guidelines on non-muscle invasive bladder cancer 2Health News:Most UK citizens susceptible to hepatitis B infection 2Health News:The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc. 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 3Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 4Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 5Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 6Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 7Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 8Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 9Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 10Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 11Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 12Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 13Health News:inVentiv Health Creates Client Development and Integration Team 2Health News:inVentiv Health Creates Client Development and Integration Team 3
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator, blunt tip, formed 10.0mm from end. Fits 0.20mm diameter holes & larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge indicating positio...
BD Visitec IOL Manipulator (Lester), 0.25 mm diameter tip angled 45 in, 10 mm from end (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles hand ridge indicating position o...
Lewicky lens manipulator. Also available in titanium....
Medicine Products: